Consistency as an endpoint in migraine clinical trials.

被引:0
|
作者
Lipton, RB
机构
[1] Albert Einstein Coll Med, Dept Neurol, Bronx, NY 10467 USA
[2] Albert Einstein Coll Med, Dept Epidemiol & Social Med, Bronx, NY 10467 USA
[3] Montefiore Headache Unit, Bronx, NY USA
[4] Innovat Med Res, Baltimore, MD USA
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:273 / 273
页数:1
相关论文
共 50 条
  • [1] Guidelines for fracture healing assessments in clinical trials. Part I: Definitions and endpoint committees
    Vannabouathong, Christopher
    Sprague, Sheila
    Bhandari, Mohit
    [J]. INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED, 2011, 42 (03): : 314 - 316
  • [2] Ancient clinical trials.
    Lewis, EJ
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (01): : 83 - 84
  • [3] Glycitein for clinical trials.
    Verbruggen, MA
    Olieman, K
    [J]. JOURNAL OF NUTRITION, 2002, 132 (03): : 601S - 601S
  • [4] Advancement in KRAS clinical trials.
    Yeung, Wayne
    [J]. CANCER RESEARCH, 2021, 81 (13)
  • [5] Clinical trials. A pending subject
    Gil-Extremera, B.
    Jimenez-Lopez, P.
    Mediavilla-Garcia, J. D.
    [J]. REVISTA CLINICA ESPANOLA, 2018, 218 (03): : 137 - 141
  • [6] Use of biomarkers in clinical trials.
    Ransohoff, DF
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2005, 14 (11) : 2768S - 2768S
  • [7] Ancient clinical trials. Reply
    Lepreau, FJ
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (01): : 84 - 84
  • [8] MUNE as an endpoint in clinical trials
    Bryan, WW
    [J]. MOTOR UNIT NUMBER ESTIMATION (MUNE), PROCEEDINGS, 2003, 55 : 324 - 328
  • [9] Planning for oncological clinical trials.
    Odeleye, OE
    Kovacevic, M
    Torchio, CR
    [J]. BLOOD, 2000, 96 (11) : 390B - 390B
  • [10] Endpoint considerations for clinical trials
    Walton, MK
    [J]. AMYOTROPHIC LATERAL SCLEROSIS AND OTHER MOTOR NEURON DISORDERS, 2002, 3 : S3 - S6